Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Effects of inclined surfaces on gait variability and stability in unilateral lower limb amputees.

Rodrigues FB, Andrade AO, Vieira MF.

Med Biol Eng Comput. 2019 Sep 10. doi: 10.1007/s11517-019-02042-6. [Epub ahead of print]

PMID:
31506856
2.

Phase Angle is Moderately Associated with Short-term Maximal Intensity Efforts in Soccer Players.

Nabuco HCG, Silva AM, Sardinha LB, Rodrigues FB, Tomeleri CM, Ravagnani FCP, Cyrino ES, Ravagnani CFC.

Int J Sports Med. 2019 Oct;40(11):739-743. doi: 10.1055/a-0969-2003. Epub 2019 Aug 22.

PMID:
31437860
3.

Huntington's Disease Clinical Trials Corner: June 2019.

Rodrigues FB, Ferreira JJ, Wild EJ.

J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.

PMID:
31381524
4.

Anti-TNF Drugs for Chronic Uveitis in Adults-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Leal I, Rodrigues FB, Sousa DC, Duarte GS, Romão VC, Marques-Neves C, Costa J, Fonseca JE.

Front Med (Lausanne). 2019 May 24;6:104. doi: 10.3389/fmed.2019.00104. eCollection 2019.

5.

Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.

Anderson DG, Ferreira-Correia A, Rodrigues FB, Aziz NA, Carr J, Wild EJ, Margolis RL, Krause A.

Mov Disord Clin Pract. 2019 Mar 12;6(4):302-311. doi: 10.1002/mdc3.12742. eCollection 2019 Apr.

PMID:
31061838
6.

Morphine in acute coronary syndrome: systematic review and meta-analysis.

Duarte GS, Nunes-Ferreira A, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J, Caldeira D.

BMJ Open. 2019 Mar 15;9(3):e025232. doi: 10.1136/bmjopen-2018-025232.

7.

Managing treatment fluctuations in Parkinson disease: "On" again-, "off" again.

Metzer WS, Rodrigues FB.

Neurology. 2019 Mar 26;92(13):597-598. doi: 10.1212/WNL.0000000000007193. Epub 2019 Mar 1. No abstract available.

PMID:
30824561
8.

Huntington's Disease Clinical Trials Corner: January 2019.

Rodrigues FB, Quinn L, Wild EJ.

J Huntingtons Dis. 2019;8(1):115-125. doi: 10.3233/JHD-190001.

PMID:
30776019
9.

Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.

Rodrigues FB, Byrne LM, De Vita E, Johnson EB, Hobbs NZ, Thornton JS, Scahill RI, Wild EJ.

Eur J Neurosci. 2019 Jun;49(12):1632-1639. doi: 10.1111/ejn.14356. Epub 2019 Feb 19.

10.

Deep brain stimulation for dystonia.

Rodrigues FB, Duarte GS, Prescott D, Ferreira J, Costa J.

Cochrane Database Syst Rev. 2019 Jan 10;1:CD012405. doi: 10.1002/14651858.CD012405.pub2.

PMID:
30629283
11.

Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitus.

Arrelias CCA, Rodrigues FB, Torquato MTDCG, Teixeira CRS, Rodrigues FFL, Zanetti ML.

Rev Lat Am Enfermagem. 2018 Nov 29;26:e3085. doi: 10.1590/1518-8345.2774.3085. English, Portuguese, Spanish.

12.

Early Prognostic Value of High-Sensitivity Troponin T after Coronary Artery Bypass Grafting.

Machado MN, Rodrigues FB, Grigolo IH, Sabbag ATR, Silva OL Júnior, Maia LN, Nakazone MA.

Thorac Cardiovasc Surg. 2019 Sep;67(6):467-474. doi: 10.1055/s-0038-1675640. Epub 2018 Nov 28.

PMID:
30485894
13.

Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.

Mestre TA, Busse M, Davis AM, Quinn L, Rodrigues FB, Burgunder JM, Carlozzi NE, Walker F, Ho AK, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 May 9;5(4):361-372. doi: 10.1002/mdc3.12617. eCollection 2018 Jul-Aug.

14.

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.

Byrne LM, Rodrigues FB, Johnson EB, Wijeratne PA, De Vita E, Alexander DC, Palermo G, Czech C, Schobel S, Scahill RI, Heslegrave A, Zetterberg H, Wild EJ.

Sci Transl Med. 2018 Sep 12;10(458). pii: eaat7108. doi: 10.1126/scitranslmed.aat7108.

PMID:
30209243
15.

Management of Small Renal Masses.

Neves JB, Rodrigues FB, Tran MGB.

Radiology. 2018 Oct;289(1):272-273. doi: 10.1148/radiol.2018181391. Epub 2018 Sep 4. No abstract available.

PMID:
30179113
16.

Huntington's Disease Clinical Trials Corner: August 2018.

Rodrigues FB, Wild EJ.

J Huntingtons Dis. 2018;7(3):279-286. doi: 10.3233/JHD-189003.

17.

Physician perception versus true efficacy of tetrabenazine for Huntington's disease.

Rodrigues FB, Ferreira JJ, Wild EJ.

Curr Med Res Opin. 2018 Sep;34(9):1537-1538. doi: 10.1080/03007995.2018.1490703. Epub 2018 Jul 19. No abstract available.

PMID:
29920125
18.

Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?

Duarte GS, Rodrigues FB, Ferreira JJ, Costa J.

Parkinsonism Relat Disord. 2018 Nov;56:16-19. doi: 10.1016/j.parkreldis.2018.06.017. Epub 2018 Jun 15. Review.

PMID:
29910156
19.

Biofluid Biomarkers in Huntington's Disease.

Rodrigues FB, Byrne LM, Wild EJ.

Methods Mol Biol. 2018;1780:329-396. doi: 10.1007/978-1-4939-7825-0_17. Review.

PMID:
29856027
20.

Perinatal insults and neurodevelopmental disorders may impact Huntington's disease age of diagnosis.

Barkhuizen M, Rodrigues FB, Anderson DG, Winkens B; REGISTRY Investigators of the European Huntington's Disease Network, Wild EJ, Kramer BW, Gavilanes AWD.

Parkinsonism Relat Disord. 2018 Oct;55:55-60. doi: 10.1016/j.parkreldis.2018.05.016. Epub 2018 May 18.

21.

Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.

Leal I, Rodrigues FB, Sousa DC, Romão VC, Duarte GS, Carreño E, Dick AD, Marques-Neves C, Costa J, Fonseca JE.

Acta Ophthalmol. 2018 Sep;96(6):e665-e675. doi: 10.1111/aos.13699. Epub 2018 Mar 25. Review.

22.

Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.

Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 May;33(5):742-749. doi: 10.1002/mds.27317. Epub 2018 Mar 23. Review.

23.

Cerebrospinal fluid neurogranin and TREM2 in Huntington's disease.

Byrne LM, Rodrigues FB, Johnson EB, De Vita E, Blennow K, Scahill R, Zetterberg H, Heslegrave A, Wild EJ.

Sci Rep. 2018 Mar 9;8(1):4260. doi: 10.1038/s41598-018-21788-x.

24.

Huntington’s Disease Clinical Trials Corner: February 2018

Rodrigues FB, Wild EJ.

J Huntingtons Dis. 2018;7(1):89-98. doi: 10.3233/JHD-189001. Review.

25.

Neurofilament light protein in blood predicts regional atrophy in Huntington disease.

Johnson EB, Byrne LM, Gregory S, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RA, Zetterberg H, Tabrizi SJ, Scahill RI, Wild EJ; TRACK-HD Study Group.

Neurology. 2018 Feb 20;90(8):e717-e723. doi: 10.1212/WNL.0000000000005005. Epub 2018 Jan 24.

26.

Botulinum toxin type A therapy for cervical dystonia.

Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C, Moore AP, Costa J.

Cochrane Database Syst Rev. 2017 Dec 12;12:CD003633. doi: 10.1002/14651858.CD003633.pub3. Review.

27.

Effects of backpack load and positioning on nonlinear gait features in young adults.

Rodrigues FB, Magnani RM, Lehnen GC, Souza GSSE, Andrade AO, Vieira MF.

Ergonomics. 2018 May;61(5):720-728. doi: 10.1080/00140139.2017.1413213. Epub 2017 Dec 11.

PMID:
29202661
28.

Meta-research metrics matter: letter regarding article "indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease".

Rodrigues FB, Duarte GS, Costa J, Ferreira JJ, Wild EJ.

J Clin Mov Disord. 2017 Nov 22;4:19. doi: 10.1186/s40734-017-0067-x. eCollection 2017.

29.

Frequency of post-stroke electroencephalographic epileptiform activity - a systematic review and meta-analysis of observational studies.

Bentes C, Rodrigues FB, Sousa D, Duarte GS, Franco AC, Marques R, Nzwalo H, Peralta AR, Ferro JM, Costa J.

Eur Stroke J. 2017 Dec;2(4):361-368. doi: 10.1177/2396987317731004. Epub 2017 Sep 13.

30.

Overall Survival and Causes of Death in Neurodegeneration-An Overlooked and Underreported Theme.

Rodrigues FB, Ferreira JJ.

JAMA Neurol. 2017 Nov 1;74(11):1379. doi: 10.1001/jamaneurol.2017.2862. No abstract available.

PMID:
29052699
31.

Clinical Trials Corner: September 2017.

Rodrigues FB, Wild EJ.

J Huntingtons Dis. 2017;6(3):255-263. doi: 10.3233/JHD-170262. Review.

32.

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?

Rodrigues FB, Duarte GS, Costa J, Ferreira JJ, Wild EJ.

Mov Disord Clin Pract. 2017 Jul-Aug;4(4):582-585. doi: 10.1002/mdc3.12483. Epub 2017 Mar 29.

33.

Intracerebral hemorrhage as a manifestation of cerebral hyperperfusion syndrome after carotid revascularization: systematic review and meta-analysis.

Abreu P, Nogueira J, Rodrigues FB, Nascimento A, Carvalho M, Marreiros A, Nzwalo H.

Acta Neurochir (Wien). 2017 Nov;159(11):2089-2097. doi: 10.1007/s00701-017-3328-4. Epub 2017 Sep 15. Review.

PMID:
28916863
34.

Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.

Caldeira D, Rodrigues FB, Duarte MM, Sterrantino C, Barra M, Gonçalves N, Pinto FJ, Ferreira JJ, Costa J.

Drug Saf. 2018 Jan;41(1):77-86. doi: 10.1007/s40264-017-0586-2. Review.

PMID:
28786035
35.

Fifteen Years of Clinical Trials in Huntington's Disease: A Very Low Clinical Drug Development Success Rate.

Travessa AM, Rodrigues FB, Mestre TA, Ferreira JJ.

J Huntingtons Dis. 2017;6(2):157-163. doi: 10.3233/JHD-170245.

PMID:
28671135
36.

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.

Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, Scahill RI, Tabrizi SJ, Zetterberg H, Langbehn D, Wild EJ.

Lancet Neurol. 2017 Aug;16(8):601-609. doi: 10.1016/S1474-4422(17)30124-2. Epub 2017 Jun 7. Erratum in: Lancet Neurol. 2017 Sep;16(9):683.

37.

Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.

Caldeira D, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J.

Clin Med Insights Blood Disord. 2017 May 8;10:1179545X17704660. doi: 10.1177/1179545X17704660. eCollection 2017. Review.

38.

Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort.

Rodrigues FB, Abreu D, Damásio J, Goncalves N, Correia-Guedes L, Coelho M, Ferreira JJ; REGISTRY Investigators of the European Huntington's Disease Network.

Mov Disord Clin Pract. 2017 May 26;4(5):737-742. doi: 10.1002/mdc3.12502. eCollection 2017 Sep-Oct.

39.

Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis.

Silva MA, Duarte GS, Camara R, Rodrigues FB, Fernandes RM, Abreu D, Mestre T, Costa J, Trenkwalder C, Ferreira JJ.

Neurology. 2017 Jun 6;88(23):2216-2224. doi: 10.1212/WNL.0000000000004004. Epub 2017 May 10. Review.

PMID:
28490647
40.

Local dynamic stability and gait variability during attentional tasks in young adults.

Magnani RM, Lehnen GC, Rodrigues FB, de Sá E Souza GS, de Oliveira Andrade A, Vieira MF.

Gait Posture. 2017 Jun;55:105-108. doi: 10.1016/j.gaitpost.2017.04.019. Epub 2017 Apr 18.

PMID:
28437756
41.

A simple, reliable method to determine the mean gait speed using heel markers on a treadmill.

Souza GSSE, Rodrigues FB, Andrade AO, Vieira MF.

Comput Methods Biomech Biomed Engin. 2017 Jun;20(8):901-904. doi: 10.1080/10255842.2017.1309395. Epub 2017 Mar 28.

PMID:
28347171
42.

Linear and Nonlinear Gait Features in Older Adults Walking on Inclined Surfaces at Different Speeds.

Vieira MF, Rodrigues FB, de Sá E Souza GS, Magnani RM, Lehnen GC, Andrade AO.

Ann Biomed Eng. 2017 Jun;45(6):1560-1571. doi: 10.1007/s10439-017-1820-x. Epub 2017 Mar 14.

PMID:
28293751
43.

Center of pressure and center of mass behavior during gait initiation on inclined surfaces: A statistical parametric mapping analysis.

Vieira MF, de Brito AA Junior, Lehnen GC, Rodrigues FB.

J Biomech. 2017 May 3;56:10-18. doi: 10.1016/j.jbiomech.2017.02.018. Epub 2017 Feb 27.

PMID:
28284667
44.

Opicapone for the treatment of Parkinson's disease.

Rodrigues FB, Ferreira JJ.

Expert Opin Pharmacother. 2017 Mar;18(4):445-453. doi: 10.1080/14656566.2017.1294683. Epub 2017 Feb 22. Review.

PMID:
28234566
45.

Gait stability, variability and complexity on inclined surfaces.

Vieira MF, Rodrigues FB, de Sá E Souza GS, Magnani RM, Lehnen GC, Campos NG, Andrade AO.

J Biomech. 2017 Mar 21;54:73-79. doi: 10.1016/j.jbiomech.2017.01.045. Epub 2017 Feb 6.

PMID:
28233553
46.

Anterior ischemic optic neuropathy and hematologic malignancy: a systematic review of case reports and case series.

Sousa DC, Rodrigues FB, Duarte G, Campos F, Pinto F, Vaz-Carneiro A.

Can J Ophthalmol. 2016 Dec;51(6):459-466. doi: 10.1016/j.jcjo.2016.05.018. Epub 2016 Sep 14. Review.

PMID:
27938958
47.

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Duarte GS, Castelão M, Rodrigues FB, Marques RE, Ferreira J, Sampaio C, Moore AP, Costa J.

Cochrane Database Syst Rev. 2016 Oct 26;10:CD004314. Review.

48.

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.

Rodrigues FB, Byrne LM, McColgan P, Robertson N, Tabrizi SJ, Zetterberg H, Wild EJ.

PLoS One. 2016 Sep 22;11(9):e0163479. doi: 10.1371/journal.pone.0163479. eCollection 2016.

49.

Effects of general fatigue induced by incremental maximal exercise test on gait stability and variability of healthy young subjects.

Vieira MF, de Sá E Souza GS, Lehnen GC, Rodrigues FB, Andrade AO.

J Electromyogr Kinesiol. 2016 Oct;30:161-7. doi: 10.1016/j.jelekin.2016.07.007. Epub 2016 Jul 14.

PMID:
27451361
50.

Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.

Rodrigues FB, Byrne L, McColgan P, Robertson N, Tabrizi SJ, Leavitt BR, Zetterberg H, Wild EJ.

J Neurochem. 2016 Oct;139(1):22-5. doi: 10.1111/jnc.13719. Epub 2016 Sep 20.

Supplemental Content

Loading ...
Support Center